| Nov 5 |
CRISPR Therapeutics Provides Business Update and Reports Third Quarter 2024 Financial Results
|
| Nov 5 |
3 Companies Building Tomorrow's Game-Changing Technologies
|
| Nov 4 |
CRISPR Therapeutics AG (CRSP) Just Overtook the 20-Day Moving Average
|
| Nov 4 |
CRISPR Therapeutics AG (CRSP) Recently Broke Out Above the 50-Day Moving Average
|
| Nov 2 |
Thinking of Buying CRISPR Therapeutics Stock? Watch These 2 Key Numbers
|
| Oct 31 |
Is CRISPR Therapeutics (CRSP) a Promising Gene Editing Stock?
|
| Oct 30 |
Crispr Therapeutics: Avoid Catching The Falling Knife This Time (Downgrade)
|
| Oct 28 |
CRISPR Therapeutics to Report Q3 Earnings: Is a Beat in Store?
|
| Oct 28 |
Crispr Therapeutics: Poised For A Major Turnaround
|
| Oct 26 |
The Ultimate Biotech Stock to Buy With $50 Right Now
|
